Nation’s Experts in Hematologic Malignancies to Discuss Latest Treatment Advances and Examine Patient Cases during NCCN 12th Annual Congress
NCCN 12th Annual Congress: Hematologic Malignancies™ will be held October 6 – 7, 2017 in San Francisco, California, and features a new Nursing Forum.
22-Sep-2017 10:15 AM EDT Add to Favorites
NCCN categories of preference will provide guidance on which recommendations within the NCCN Guidelines are optimal, while providing a range of recommendations to accommodate a variety of clinical circumstances.
15-Sep-2017 12:00 PM EDT Add to Favorites
Providing access to NCCN Templates® through MEDITECH’s Web EHR offers practitioners up-to-date, evidence-based cancer treatment protocols at the point of care to assist in shared decision-making.
7-Sep-2017 10:05 AM EDT Add to Favorites
NCCN Announces First Patient Dosed in NCCN-Peregrine Pharmaceuticals Collaborative Study of Bavituximab
An NCCN ORP-funded study, examining effectiveness of bavituximab combination in patients with newly diagnosed glioblastomas, enrolled its first patient at Dana-Farber Cancer Institute in Boston, Massachusetts.
7-Sep-2017 8:05 AM EDT Add to Favorites
Integration of the NCCN Content into the Evinance Decision Support Platform will provide clinicians with access to the latest evidence-based treatment information at the point of care.
23-Aug-2017 9:00 AM EDT Add to Favorites
Together with the NCCN Guidelines for Patients®: Colon Cancer, these free resources aid in decision-making for patients with colon and rectal cancers.
10-Aug-2017 10:05 AM EDT Add to Favorites
As published in JNCCN – Journal of the National Comprehensive Cancer Network, researchers at UT Southwestern Medical Center found significant racial and gender-based disparities in outcomes among patients with locoregional anal cancer.
9-Aug-2017 10:05 AM EDT Add to Favorites
100 cancer centers throughout the country have pledged to adopt a life-saving administration policy for vincristine
7-Aug-2017 2:30 PM EDT Add to Favorites